1. Home
  2. ABSI vs AIAI Comparison

ABSI vs AIAI Comparison

Compare ABSI & AIAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Absci Corporation

ABSI

Absci Corporation

N/A

Current Price

$7.14

Market Cap

997.8M

Sector

Health Care

ML Signal

N/A

AIAI

AIAI Holdings Corporation Class A Common Stock

N/A

Current Price

$5.56

Market Cap

1.0B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ABSI
AIAI
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
997.8M
1.0B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ABSI
AIAI
Price
$7.14
$5.56
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$6.96
N/A
AVG Volume (30 Days)
4.0M
171.0K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
10.64
N/A
EPS
N/A
N/A
Revenue
$4,534,000.00
N/A
Revenue This Year
$215.96
N/A
Revenue Next Year
$319.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.24
$5.21
52 Week High
$12.06
$18.88

Technical Indicators

Market Signals
Indicator
ABSI
AIAI
Relative Strength Index (RSI) 34.84 19.73
Support Level $2.56 N/A
Resistance Level $12.06 $7.56
Average True Range (ATR) 0.71 1.18
MACD -0.44 -0.20
Stochastic Oscillator 5.44 4.13

Price Performance

Historical Comparison
ABSI
AIAI

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Share on Social Networks: